Safety profile of recombinant adeno- associated viral vectors: focus on alipogene tiparvovec (Glybera. Expert Rev Clin Pharmacol. Large- scale processing of recombinant retroviruses for gene therapy. Lentiviral vectors: optimization of packaging, transduction and gene expression. Gene therapy of human severe combined immunodeficiency (SCID)- X1 disease. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J Clin Invest. 11. Gene therapy for PIDs: progress, pitfalls and prospects. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott. Science. 34. 1: 1. Cartier, N, Hacein- Bey- Abina, S, Bartholomae, CC, Veres, G, Schmidt, M, Kutschera, Iet al. Hematopoietic stem cell gene therapy with a lentiviral vector in X- linked adrenoleukodystrophy. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science. 34. 1: 1. Cavazzana- Calvo, M, Payen, E, Negre, O, Wang, G, Hehir, K, Fusil, Fet al. Transfusion independence and HMGA2 activation after gene therapy of human . Long- term safety and tolerability of Pro. Savin, a lentiviral vector- based gene therapy for Parkinson. Performance- enhancing drugs: design and production of redirected chimeric antigen receptor (CAR) T cells. Cancer Gene Ther. Identification of a human immunodeficiency virus type 2 (HIV- 2) encapsidation determinant and transduction of nondividing human cells by HIV- 2- based lentivirus vectors. Generation of replication- defective helper- free vectors based on simian immunodeficiency virus. Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors. Gene transfer systems derived from Visna virus: analysis of virus production and infectivity. Gene transfer system derived from the caprine arthritis- encephalitis lentivirus. J Virol Methods. 13. Stable gene transfer to the nervous system using a non- primate lentiviral vector. Overview of the HIV- 1 lentiviral vector system. Curr Protoc Mol Biol (Chapter 1. Unit 1. 6. 2. 1). Dull, T, Zufferey, R, Kelly, M, Mandel, RJ, Nguyen, M, Trono, Det al. A third- generation lentivirus vector with a conditional packaging system. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. Development of a self- inactivating lentivirus vector. ![]() Self- inactivating lentivirus vector for safe and efficient in vivo gene delivery. Design and production of retro- and lentiviral vectors for gene expression in hematopoietic cells. Methods Mol Biol. Efficient construction of producer cell lines for a SIN lentiviral vector for SCID- X1 gene therapy by concatemeric array transfection. Strategies for targeting lentiviral vectors. Synthesis, assembly, and processing of viral proteins. In: Coffin, J, Hughes, SH and Varmus, H (eds.). Gene Therapy (2005) 12, S36–S50. Real-time quantitative PCR for the design of lentiviral vector analytical assays. Our Lentiviral Expression Vectors are designed to work with any 2nd or 3rd generation lentiviral packaging system. However, they are optimized to produce the highest. Our lentivirus reagent portfolio will ensure you get exceptional results from your expression studies. See how we can help you today! Key properties of a viral vector. Viral vectors are tailored to their specific applications but generally share a few key properties. Safety: Although viral vectors. Cold Spring Harbor Laboratory Press: Cold Spring Harbor/NY, pp. A Rev- independent human immunodeficiency virus type 1 (HIV- 1)- based vector that exploits a codon- optimized HIV- 1 gag- pol gene. Rev- independent expression of synthetic gag- pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors. Hum Gene Ther. 11: 2. Certification assays for HIV- 1- based vectors: frequent passage of gag sequences without evidence of replication- competent viruses. A Rev- independent gag/pol eliminates detectable psi- gag recombination in lentiviral vectors. Biores Open Access. The HIV- 1 Rev response element: an RNA scaffold that directs the cooperative assembly of a homo- oligomeric ribonucleoprotein complex. Continuous propagation of RRE(. Requirements for efficient production and transduction of human immunodeficiency virus type 1- based vectors. Identification of a novel posttranscriptional regulatory element by using a rev- and RRE- mutated human immunodeficiency virus type 1 DNA proviral clone as a molecular trap. Design, production, safety, evaluation, and clinical applications of nonprimate lentiviral vectors. Methods Enzymol. 34. Gene transfer in humans using a conditionally replicating lentiviral vector. Proc Natl Acad Sci USA1. Safe two- plasmid production for the first clinical lentivirus vector that achieves > 9. QC release testing of an HIV- 1 based lentiviral vector lot and transduced cellular product. Lentivirus production is influenced by SV4. T- antigen and chromosomal integration of the vector in HEK2. Hum Gene Ther. 22: 1. Large- scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application. Production of CGMP- grade lentiviral vectors. Advantages of COS- 1 monkey kidney epithelial cells as packaging host for small- volume production of high- quality recombinant lentiviruses. J Virol Methods. 15. Small- to large- scale production of lentivirus vectors. Methods Mol Biol. A new technique for the assay of infectivity of human adenovirus 5 DNA. ![]() Lentiviral Vector Production and Cell Transduction Lentiviral vectors derived from the human immunodeficiency virus (HIV-1) have become major tools for gene delivery in. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA9. Simplified lentivirus vector production in protein- free media using polyethylenimine- mediated transfection. J Virol Methods. 15. Large- scale transfection of mammalian cells for the fast production of recombinant protein. Mol Biotechnol. 34: 2. Production, concentration and titration of pseudotyped HIV- 1- based lentiviral vectors. Modification of HEk 2. Mol Ther. 9: S3. 3. Slepushkin, V, Chang, N, Cohen, R, Gan, Y, Jiang, B, Deausen, E, et al. Large- scale purification of a lentiviral vector by size exclusion chromatography or Mustang Q ion exchange chromatography. Comparison of transfection conditions for a lentivirus vector produced in large volumes. Hum Gene Ther. 14: 1. Long- term correction of murine beta- thalassemia following busulfan conditioning and transplant of bone marrow transduced with clinical- grade lentiviral vector (Lenti. Globin. Mol Ther. S8. 5. Dupont, F (2. Large Scale Manufacturing of a Lentiviral Vector (Pro. Savin. Presented at the CONSERT Labcourse, Evry/F, 2. June. Transduction of human CD3. SCID- X1 produced at clinical scale by a stable cell line. Hum Gene Ther Methods. Methods Mol Med. 69: 3. Methods Mol Med. 69: 2. Production and concentration of pseudotyped HIV- 1- based gene transfer vectors. Harvest Timing and Media Composition Effects on Lentiviral Vector Production. Presented at the 8th Annual Meeting of the ASGT, 1 June. Louis, MO. Couture, LA (2. Vector Production in Support of Early Clinical Trials. Presented at the ASGT Meeting, 2. May. Large- scale production of lentiviral vector in a closed system hollow fiber bioreactor. Mol Ther Methods Clin Dev. Marceau, N and Gasmi, M, Scalable lentiviral vector production system compatible with industrial pharmaceutical applications, WO 2. A1 (2. 01. 3). Witting, SR, Li, LH, Jasti, A, Allen, C, Cornetta, K, Brady, Jet al. Efficient large volume lentiviral vector production using flow electroporation. Development of a scalable process for high- yield lentiviral vector production by transient transfection of HEK2. High- level and high- throughput recombinant protein production by transient transfection of suspension- growing human 2. EBNA1 cells. Nucleic Acids Res. E9. Tom, R, Bisson, L and Durocher, Y (2. Transfection of HEK2. EBNA1 cells in suspension with linear PEI for production of recombinant proteins. CSH Protoc. 20. 08: pdb. Jaalouk, DE, Crosato, M, Brodt, P and Galipeau, J (2. Inhibition of histone deacetylation in 2. GPG packaging cell line improves the production of self- inactivating MLV- derived retroviral vectors. Virol J3: 2. 7. Sena- Esteves, M, Tebbets, JC, Steffens, S, Crombleholme, T and Flake, AW (2. Optimized large- scale production of high titer lentivirus vector pseudotypes. J Virol Methods. 12. Tight control of gene expression in mammalian cells by tetracycline- responsive promoters. Proc Natl Acad Sci USA8. Inducible human immunodeficiency virus type 1 packaging cell lines. Regulated lentiviral packaging cell line devoid of most viral cis- acting sequences. Generation of a stable cell line producing high- titer self- inactivating lentiviral vectors. A trans- lentiviral packaging cell line for high- titer conditional self- inactivating HIV- 1 vectors. Generation of a packaging cell line for prolonged large- scale production of high- titer HIV- 1- based lentiviral vector. Continuous high- titer HIV- 1 vector production. Nat Biotechnol. 21: 5. Generation of a lentiviral vector producer cell clone for human Wiskott. Mol Ther Methods Clin Dev. Bonner, M, Ma, Z, Zhou, S, Ren, A, Chandrasekaran, A, Gray, JT, et al. Development of a Second Generation Stable Lentiviral Packaging Cell Line In Support Of Clinical Gene Therapy Protocols. In: 1. 8th ASGCT Annual Meeting, New Orleans. Hu, P, Li, Y, Sands, MS, Mc. Cown, T and Kafri, T (2. Generation of a stable packaging cell line producing high- titer PPT- deleted integration- deficient lentiviral vectors. Mol Ther Methods Clin Dev. Stewart, HJ, Leroux- Carlucci, MA, Sion, CJ, Mitrophanous, KA and Radcliffe, PA (2. Development of inducible EIAV- based lentiviral vector packaging and producer cell lines. A stable producer cell line for the manufacture of a lentiviral vector for gene therapy of Parkinson. Inducible packaging cells for large- scale production of lentiviral vectors in serum- free suspension culture. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV- 1 accessory proteins. Generation of a flexible cell line with regulatable, high- level expression of HIV Gag/Pol particles capable of packaging HIV- derived vectors. Construction of stable packaging cell lines for clinical lentiviral vector production. Sci Rep. 5: 9. 02. Coroadinha, AS, Schucht, R, Gama- Norton, L, Wirth, D, Hauser, H and Carrondo, MJ (2.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
October 2017
Categories |